
Richard David Berkowitz MD
Hip & Knee Reconstructive Surgery
Physician
Join to view full profile
7171 N University DrSuite 100Tamarac, FL 33321
Phone+1 954-718-7776
Fax+1 954-597-7773
Dr. Berkowitz is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
McGill University Faculty Medicine HospitalOrthopedic Surgery, 1990 - 1995
Albert Einstein Medical CenterInternship, Transitional Year, 1988 - 1989
Drexel University College of MedicineClass of 1988
Certifications & Licensure
CA State Medical License 1994 - Present
FL State Medical License 1996 - 2027
PA State Medical License 1995 - 1996
American Board of Orthopaedic Surgery Orthopaedic Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification CGM CLINICAL, CompuGroup Medical, 2014-2015
- CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2014-2015
Publications & Presentations
PubMed
- 3 citationsHTX-011 in Combination with Multimodal Analgesic Regimen Minimized Severe Pain and Opioid Use after Total Knee Arthroplasty in an Open-Label Study.Gwo-Chin Lee, Richard Berkowitz, Scott Hacker, Jia Hu, Alan Rechter
The Journal of Knee Surgery. 2023-07-01 - 14 citationsSafety and Efficacy of Perioperative Intravenous Meloxicam for Moderate-to-Severe Pain Management in Total Knee Arthroplasty: A Randomized Clinical Trial.Richard D Berkowitz, Richard Steinfeld, Alexander P. Sah, Randall J Mack, Stewart W. McCallum
Pain Medicine. 2021-06-04 - 15 citationsMeloxicam for intravenous use: review of its clinical efficacy and safety for management of postoperative pain.Richard D Berkowitz, Randall J Mack, Stewart W. McCallum
Pain Management. 2021-05-01
Press Mentions
TKA Study: 32% Less Opioids with MeloxicamMay 11th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









